Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  16 (2024)
Volume  15 (2023)
Volume  14 (2022)
Volume  13 (2021)
Volume  12 (2020)
Volume  11 (2019)
Volume  10 (2018)
Volume  9 (2017)
Volume  8 (2016)
Volume  7 (2015)
Volume  6 (2014)
Volume  5 (2013)
Volume  4 (2012)
Volume  3 (2011)
Volume  2 (2010)
Volume  1 (2009)
Related articles

VOLUME 7 , ISSUE 3 ( September-December, 2015 ) > List of Articles

RESEARCH ARTICLE

The Role of Natural Progesterone Administration on the Levels of Progesterone-induced Blocking Factor, Interleukin-10 and the Prolongation of Gestational Length in Impending Preterm Delivery

Yanne Thipasary, Jusuf Sulaeman Effendi, Anita Deborah Anwar

Citation Information : Thipasary Y, Effendi JS, Anwar AD. The Role of Natural Progesterone Administration on the Levels of Progesterone-induced Blocking Factor, Interleukin-10 and the Prolongation of Gestational Length in Impending Preterm Delivery. J South Asian Feder Obs Gynae 2015; 7 (3):118-125.

DOI: 10.5005/jp-journals-10006-1340

Published Online: 01-03-2017

Copyright Statement:  Copyright © 2015; The Author(s).


Abstract
PDF Share
  1. National, regional and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. The Lancet 2012 Jun;379(9832):2162-2172.
  2. The epidemiology of preterm labour and delivery. In: Norman JE, Greer I, editors. Preterm Labour, Managing Risk in Clinical Practice. 1st ed: Cambridge University; 2005. p. 1-25.
  3. Riset Kesehatan Dasar 2007. Jakarta: Departemen Kesehatan RI; 2008.
  4. Pedoman diagnosis dan terapi obstetri dan Ginekologi Dr. Rumah Sakit Hasan Sadikin. 1st ed. 2005.
  5. Inflammation in preterm and term delivery. Sem in Fetal and Neonatal Med 2006;11(5):317-326.
  6. Inflammatory processes in preterm and term parturition. J Reproduct Immunol 2008;79(1):50-57.
  7. Progesterone interactions with the cervix: translational implications for term and preterm birth. Infectious Dis Obstet Gynecol 2011;2011(353297):1-13.
  8. Premature delivery of foetal lambs infused with glucocorticoids. J Endocrinol 1969;45(4):515-523.
  9. Inflammation and Pregnancy. Rep Sci 2009;16(2): 206-215.
  10. The Th1: th2 dichotomy of pregnancy and preterm labour. Mediators of inflammation 2012;2012(967629):1-12.
  11. Th1/Th2 cytokines balance yin and yang of reproductive immunology. Eur J Obstet Gynecol Reproduct Biol 2005;122(2):136-143.
  12. Biology of parturition. In: Creasy RK, Resnik R, Iams JD, Lockwood CJ, Moore TR, editors. Maternal and Fetal Medicine. 6th ed. California: WB Saunders; 2009. p. 69-80.
  13. Pathogenesis of spontaneous preterm labor. In: Creasy RK, Resnik R, Iams JD, Lockwood CJ, Moore TR, editor. Maternal and Fetal Medicine. 6th ed. California: WB Saunders; 2009. p. 522-532.
  14. Yen and Jaffe's reproductive endocrinology: physiology, pathophysiology, and clinical management. 6th ed. Philadelphia, PA: Saunders/Elsevier; 2009.
  15. Membrane progesterone receptor expression in mammalian tissues: a review of regulation and physiological implications. Steroids [Review] 2011;76(1-2):11-17.
  16. Expression of membrane progesterone receptors on human T lymphocytes and Jurkat cells and activation of G-proteins by progesterone. J Endocrinol 2008;196:67-77.
  17. The immune system & reproductive processes: highlights from the postgraduate course. In: Lockwood CJ, editor. 54th Annual Scientific Meeting of the Society for Gynecologic Investigation; 2007; Philadelphia. Society for Gynecologic Investigation; 2007. p. 27-31.
  18. Progesterone and the immunology of pregnancy. J Steroid Biochemistry Molecular Biol 2005;97(5):389-396.
  19. Progesterone-induced blocking factor (PIBF) modulates cytokine production by lymphocytes from women with recurrent miscarriage or preterm delivery. J Reproduct Immunol 2009;80(1-2):91-99.
  20. Progesterone as an immunomodulatory molecule. Int Immun Phar 2001;1(6):1037-1048.
  21. Progesterone for recurrent miscarriage: truth and deceptions. Prac Res Clin Obstet Gynaecol 2008; 22(2):375-389.
  22. Labor-associated changes in interleukin-10 production and its regulation by immunomodulators in human choriodecidua. J Clin Endoc Metab 2007;83(12):4332-4337.
  23. Cytokine secretion in decidual mononuclear cells from term human pregnancy with or without labour: ELISPOT detection of IFN-g, IL-4, IL-10, TGF-and TNF-a. J Rep Imm 2006;71(1):41-56.
  24. The changing role of progesterone in preterm labour. BJOG 2005;112(1):57-60.
  25. Prevention of preterm birth based on short cervix: progesterone. Seminars Perinatol 2009;33(5):334-337.
  26. Williams Obstetrics. 23rd ed. The McGraw-Hill Companies Inc; 2010.
  27. The effectiveness of medical interventions aimed at preventing preterm birth: a literature review. Women and Birth 2011;24(4):141-147.
  28. Prematurity prevention: the role of progesterone. Current Opinion Obstet Gynecol 2009;21(2):142-147.
  29. Progesterone and preterm birth prevention: Translating Clinical Trials Data into Clinical Practice. Am J Obstet Gynecol 2012;206(5):376-386.
  30. Progesterone and the risk of preterm birth among women with a short cervix. New England J Med 2007;357(5):462-469.
  31. Role of micronised progesterone in prevention of preterm labour in high risk pregnancies. Int J Pharm Res Sci 2013;2(1):458-462.
  32. The ‘see-saw’ theory of parturition. CIBA Found 1977;47:159-210.
  33. The role of progesterone in prevention of preterm birth. Int J Women's Health 2009;1:73-84.
  34. Follow-up of children exposed in utero to 17 alpha-hydroxyprogesterone caproate compared with placebo. Obstet Gynecol 2007;110(4):865-872.
  35. Dydrogesterone supplementation in women with threatened preterm delivery— the impact on cytokine profile, hormone profile, and progesterone-induced blocking factor. J Reproduct Immunol 2011;92(1-2):103-107.
  36. Am J Obstet Gynecol [Practice Guideline] 2012;206(5):376-386.
  37. Progesterone for the prevention of preterm birth: indications, when to initiate, efficacy and safety. Theurapeutic and Clinical Risk Manag 2009;5(1):55-64.
  38. The epidemiology of preterm Birth. In: Berghella V, editor. Preterm Birth: prevention and management. 1st ed. Blackwell Publishing Ltd; 2010. p. 22-34.
  39. Progesterone-induced blocking factor and cytokine profile in women with threatened preterm delivery. Am J Reproduct Immunol 2009;61(5):330-337.
  40. Calcium channel blockers as tocolytics: Principles of their actions, adverse effects and therapeutic combinations. Pharmaceuticals 2013;6(6):689-699.
  41. Immune aspects and myometrial actions of progesterone and CRH in labor. Clinical and Development Immunol 2012; 2012(937618):1-10.
  42. Progesterone-induced blocking factor (PIBF) and Th(1)/Th(2) cytokine in women with threatened spontaneous abortion. J Perinat Med 2009;37(4):338-342.
  43. Prediction of spontaneous preterm delivery in women with threatened preterm labour: a prospective cohort study of multiple proteins in maternal serum. BJOG 2012;119(7):866-873.
  44. Paradoxical proinflammatory actions of interleukin-10 in human amnion: potential roles in term and preterm labor. J Clin Endoc Metab 2004;89(8): 4149-4152.
  45. Projected benefits of universal or scheduled antepartum corticosteroids to prevent neonatal morbidity: a decision analysis. Am J Obstet Gynecol 2005;193(4):1415-1423.
  46. Urinary progesterone-induced blocking factor concentration is related to pregnancy outcome. Bio Reproduct 2004;71(5):1699-1705.
  47. Progesterone increase apoptosis and interleukin 10 secretion by mature monocyte derived dendritic cells. Biotechnol 2007;21(4): 468-470.
  48. Progesterone in human pregnancy and parturition. In: Dubey RK, editor. Sex Hormones. 1st ed. Intech; 2012.
  49. Hormones, immune response, and pregnancy in healthy women and SLE patients. Swiss Med Wkly 2010; 140(13-14):187-201.
  50. Sex hormones and autoimmunity. Immunol Letters 2010;133(1):6-13.
  51. Interleukin-10 attenuates experimental fetal growth restriction and demise. FASEB J 1998;12(2):189-197.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.